Drug Type Small molecule drug |
Synonyms BSO, NSC-326231 |
Target |
Action inhibitors |
Mechanism GCLC inhibitors(Gamma-glutamylcysteine synthetase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC8H18N2O3S |
InChIKeyKJQFBVYMGADDTQ-UHFFFAOYSA-N |
CAS Registry5072-26-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Buthionine Sulphoximine | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuroblastoma | NDA/BLA | China | 28 Sep 2011 | |
| Neuroblastoma | NDA/BLA | China | 28 Sep 2011 | |
| Neuroblastoma | NDA/BLA | China | 28 Sep 2011 | |
| Breast Cancer | NDA/BLA | China | 28 Sep 2011 | |
| Breast Cancer | NDA/BLA | China | 28 Sep 2011 | |
| Breast Cancer | NDA/BLA | China | 28 Sep 2011 | |
| Glioma | NDA/BLA | China | 28 Sep 2011 | |
| Glioma | NDA/BLA | China | 28 Sep 2011 | |
| Glioma | NDA/BLA | China | 28 Sep 2011 | |
| Non-Small Cell Lung Cancer | NDA/BLA | China | 28 Sep 2011 |
Not Applicable | - | - | 50mM BSO | qcgftqvngc(oyybufrzfc) = xpkyzejwgo jgbtsudufz (whtjzawmlc ) | - | 01 Jul 2019 | |
50mM BSO + 4mM GME | qcgftqvngc(oyybufrzfc) = rjpgrzfdkk jgbtsudufz (whtjzawmlc ) |





